Dosing and Outcomes Study of Erythropoiesis-stimulating Therapies (DOSE): A registry for characterizing anemia management and outcomes in oncology patients
Article
March 1, 2008
To report the design, methodology, implementation and initial results of the Dosing and Outcomes Study of Erythropoiesis-Stimulating Therapies (DOSE) Registry, the first US patient registry to collect and report on practice patterns and outcomes associated with erythropoiesis-stimulating therapy (EST) for anaemia management in oncology patients
Capabilities
Regions
North America